Sign In
Sign Up
Two Blokes
MAIA Biotechnology Receives FDA's Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung Cancer
click to rate
Posted by
Two Blokes
Jul 28
- Filed in
Stock
- 2 views
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology Receives FDA's Fast Track Designation for Ateganosine as a Treatment for Non-Small Cell Lung Cancer.
